Product image of Nebcina (Tobramycin) supplied by GNH India

Nebcina

Active Ingredient:
Tobramycin
Origin:
EU

Nebcina (Tobramycin)

Tobramycin, the active ingredient in Nebcina, is an aminoglycoside antibiotic presented as a sterile injectable solution for intramuscular and intravenous use. It treats serious infections caused by susceptible Gram‑negative bacteria, including Pseudomonas aeruginosa, in hospitalized patients.

GNH India supplies Nebcina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to European Union quality standards and provides reliable logistics for global healthcare providers.

Manufacturer / TM Owner

Viatris Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Nebcina (tobramycin) is employed to treat severe infections caused by Gram‑negative bacteria, particularly Pseudomonas aeruginosa.
  • Pseudomonas aeruginosa infections: provides bactericidal activity against systemic infections caused by this pathogen.
  • Gram‑negative sepsis: used to eradicate bloodstream infections from susceptible organisms.
  • Complicated intra‑abdominal infections: administered as part of combination therapy for severe abdominal infections.

How It Works

  • Tobramycin binds to the bacterial 30S ribosomal subunit, causing misreading of messenger RNA and inhibition of protein synthesis. This disruption leads to rapid bactericidal activity against susceptible Gram‑negative organisms, including Pseudomonas aeruginosa, without affecting human ribosomes.

Side Effects

Tobramycin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nephrotoxicity: elevated serum creatinine and reduced urine output.
  • Ototoxicity: tinnitus, vertigo, or hearing loss.
  • Neuromuscular blockade: muscle weakness, especially with anesthetics.
  • Injection site reactions: pain, erythema, or swelling.
  • Rash or mild skin eruptions.
  • Nausea or vomiting.

Serious or Rare Side Effects

  • Acute renal failure requiring dialysis.
  • Permanent sensorineural hearing loss.
  • Severe allergic reactions, including anaphylaxis.
  • Respiratory paralysis due to neuromuscular blockade.
  • Thrombocytopenia or other hematologic abnormalities.

Precautions & Warnings

  • When using Nebcina, clinicians should observe several precautionary measures to minimize risk.
  • Renal function monitoring: assess serum creatinine and urine output before and during therapy.
  • Auditory monitoring: perform baseline and periodic hearing tests to detect ototoxicity.
  • Neuromuscular blockade risk: avoid use in patients with myasthenia gravis or receiving muscle relaxants.
  • Concurrent nephrotoxic drugs: adjust dose or discontinue other agents such as vancomycin or loop diuretics.
  • Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Tobramycin can interact with other medicines, altering its efficacy or toxicity profile.

Major Interactions (Avoid)

  • Concurrent nephrotoxic agents (e.g., vancomycin, amphotericin B): increase risk of renal injury.
  • Neuromuscular blocking drugs (e.g., pancuronium): potentiate respiratory paralysis.
  • Other ototoxic drugs (e.g., furosemide, cisplatin): heighten hearing loss risk.
  • Loop diuretics: may enhance nephrotoxicity.

Moderate Interactions (Monitor Closely)

  • Other aminoglycosides: additive toxicity; avoid simultaneous use.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may affect renal clearance.
  • Beta‑lactam antibiotics: monitor for synergistic effect but adjust dosing if needed.

Frequently Asked Questions

Nebcina contains tobramycin, an aminoglycoside antibiotic indicated for the treatment of serious infections caused by susceptible Gram‑negative bacteria, especially Pseudomonas aeruginosa, in hospitalized patients.

Tobramycin binds to the bacterial 30S ribosomal subunit, causing misreading of messenger RNA and halting protein synthesis. This bactericidal action rapidly kills susceptible Gram‑negative organisms without affecting human ribosomes.

The dosage of Nebcina is determined by the prescribing clinician based on infection type, severity, patient weight, renal function, and susceptibility data. No fixed regimen is provided here.

Safety data for tobramycin in pregnancy and lactation are limited; it is classified as a category with unknown risk. Use only if the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the Nebcina product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Compared with other aminoglycosides such as gentamicin, tobramycin offers similar broad‑spectrum activity but generally shows higher potency against Pseudomonas aeruginosa. Toxicity profiles are comparable, though dosing intervals may differ; clinicians choose based on susceptibility patterns and patient-specific factors.

Nebcina should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen or shaken. Use aseptic technique when preparing the solution for injection, and discard any product that appears discolored or contains particles.

Nebcina is supplied as a sterile injectable solution for intramuscular or intravenous injection. Administration is performed by qualified healthcare professionals, with dosage adjusted according to renal function and therapeutic drug monitoring where appropriate.

The most serious adverse effects include nephrotoxicity leading to acute renal failure, ototoxicity that can cause permanent hearing loss, and neuromuscular blockade resulting in respiratory paralysis, especially in patients with pre‑existing conditions or receiving interacting medications.

Nebcina is contraindicated in patients with known hypersensitivity to tobramycin or other aminoglycosides, and should be avoided in individuals with myasthenia gravis, severe renal impairment, or those receiving concurrent nephrotoxic or ototoxic agents without careful monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Tobramycin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT